ロード中...
Treatment-resistant severe capecitabine-induced diarrhoea resolved with oral budesonide
Chemotherapy-induced diarrhoea (CID) is a risk of antineoplastic regimens, often associated with 5-fluorouracil (5-FU), irinotecan and capecitabine. Current treatment guidelines for CID include the use of loperamide and octreotide but do not account for other therapies, including budesonide. Small c...
保存先:
| 出版年: | BMJ Case Rep |
|---|---|
| 主要な著者: | , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
BMJ Publishing Group
2019
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6887426/ https://ncbi.nlm.nih.gov/pubmed/31791985 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/bcr-2019-231544 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|